Niranjan Kameswaran | SVP, Strategy |
Mary Reumuth | CFO |
Mark Iwicki | Chairman, President and CEO |
Kim Brazzell | Chief Medical Officer |
Todd Bazemore | COO |
Hongming Chen | Chief Scientific Officer |
Christopher Neyor | JPMorgan |
Kit Ma | Jefferies |
Yi Chen | H.C. Wainwright |
François Brisebois | Oppenheimer |
Tazeen Ahmad | Bank of America |
Andreas Argyrides | Wedbush Securities |
Good morning, and welcome to Kala Pharmaceuticals Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals. Please proceed.
Thank you, operator, and thank you all for participating in today's call.